ICD-10-CM Billable Code

Q75.1

Craniofacial dysostosis

Clinical Classification Guidelines

Inclusion Terms

  • Crouzon's disease

Medical Intelligence & Overview

Craniofacial dysostosis, also known as Crouzon's disease, is a genetic condition characterized by abnormal growth of the bones in the skull and face. This condition leads to distinctive facial features and skull shape, often affecting vision, breathing, and dental development. Patients with this disorder are born with these cranial and facial characteristics, which typically become more apparent as they grow.

Causes & Symptoms

Clinical Causes: Mutations in the FGFR2 gene (Fibroblast Growth Factor Receptor 2), which plays a critical role in bone development and growth. Inherited genetic factors passed from parents to children. Spontaneous genetic mutations that occur during reproductive cell formation, without a prior family history.

Key Symptoms: Fusion or premature closing of certain skull sutures, leading to an abnormally shaped skull (craniosynostosis). Flattened or bulging forehead (frontal bossing). Protruding eyes (ocular proptosis) due to shallow eye sockets. Beaked or prominent middle part of the face (midface hypoplasia). Wide-set, sparse, or undersized teeth. Misaligned bite (malocclusion). Hydrocephalus, in some cases, causing increased intracranial pressure. Possible hearing loss or ear infections stemming from middle ear issues. Signs of breathing difficulties, especially if the midface is underdeveloped.

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a combination of clinical evaluation and imaging studies. Doctors typically perform physical examinations to assess facial and skull structure, followed by imaging tests such as CT scans or X-rays to analyze skull sutures and bone development. Genetic testing can identify mutations in the FGFR2 gene, confirming the diagnosis. Early diagnosis is vital for planning appropriate management and intervention.

Treatment Protocols: Management of craniofacial dysostosis is multidisciplinary, aiming to correct skull and facial deformities and address functional issues. Treatment options include: - **Surgical Intervention:** Procedures to release fused sutures, reshape the skull, and advance facial bones to improve appearance and function. Cranial vault remodeling can be performed in infancy or early childhood. - **Orofacial Surgery:** Corrects dental malocclusions and midface hypoplasia, often involving orthognathic surgery. - **Vision and Eye Care:** Regular eye exams and corrective measures for proptosis or visual impairment. - **Hearing Management:** Monitoring and treating ear infections or hearing loss. - **Supportive Therapies:** Speech therapy and psychological support to assist with communication and social development. Ongoing follow-up is essential to address emerging issues as the child grows, and early intervention improves outcomes and quality of life.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Q75.1 a billable ICD-10 code?
Yes, Q75.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Q75.1?
Clinical documentation must specify the nature of Craniofacial dysostosis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference